...
首页> 外文期刊>Analytical chemistry >Separation of Plasma from Whole Human Blood in a Continuous Cross-Flow in a Molded Microfluidic Device
【24h】

Separation of Plasma from Whole Human Blood in a Continuous Cross-Flow in a Molded Microfluidic Device

机译:在模制微流控设备中以连续错流方式从全血中分离血浆

获取原文
获取原文并翻译 | 示例
           

摘要

We designed, fabricated, and tested a microfluidic device for separation of plasma from whole human blood by size exclusion in a cross-flow. The device is made of a single mold of a silicone elastomer poly(dimethylsiloxane) (PDMS) sealed with a cover glass and is essentially disposable. When loaded with blood diluted to 20percent hematocrit and driven with pulsatile pressure to prevent clogging of the channels with blood cells, the device can operate for at least 1 h, extracting approx8percent of blood volume as plasma at an average rate of 0.65 (mu)L/min. The flow in the device causes very little hemolysis; the extracted plasma meets the standards for common assays and is delivered to the device outlet approx30 s after injection of blood to the inlet. Integration of the cross-flow microchannel array with on-chip assay elements would create a microanalysis system for point-of-care diagnostics, reducing costs, turn-around times, and volumes of blood sample and reagents required for the assays.
机译:我们设计,制造和测试了一种微流控设备,该设备可通过大小不等的交叉流从全血中分离血浆。该设备由用盖玻片密封的硅酮弹性体聚二甲基硅氧烷(PDMS)的单个模具制成,基本上是一次性的。当装有稀释至20%的血细胞比容的血液并用脉动压力驱动以防止血细胞堵塞通道时,该设备可以运行至少1小时,以大约0.65μL的平均速度提取血浆的8%的血容量/分钟。设备中的血流几乎不会引起溶血。提取的血浆符合常规测定的标准,并在将血液注入入口后约30 s输送至设备出口。交叉流微通道阵列与芯片化验元件的集成将创建用于即时诊断的微分析系统,从而降低成本,周转时间以及化验所需的血液样本和试剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号